Gourt > Health > Pharmacy > Drugs and Medications > A > Amineptine
Amineptine (Maneon® (Italy), Survector® (Spain, Italy, Philippines) is an atypical tricyclic antidepressant that selectively inhibits the reuptake of dopamine and to a lesser extent norepinephrine, thus exerting a powerful and fast-acting antidepressant effect.
Introduced in France in 1978 by the pharmaceutical giant Servier and marketed under the trade name Survector®, amineptine soon gained a reputation for abuse due to its short-lived, but pleasant, stimulant effect experienced by some patients. (This is to be distinguished from its antidepressant effect, which appears in approximately 7 days after commencing treatment.) This led to the Food and Drug Administration suspending the marketing authorisation for Survector® in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until 2005.
Currently amineptine is off-patent and very difficult to obtain. Rare cases of hepatotoxicity, some serious, have been reported, but these were thought to be due to a genetic predisposition.
More on [ Amineptine ]
RT @psycho_babel please welcome stronge http://tiny.dr-bob.org/pr9y (amineptine)
Dr_Bob (robert hsiung) Mon, 14 Dec 2009 14:44:00 -0000
RT @psycho_babel please welcome stronge http://tiny.dr-bob.org/pr9y (amineptine)
Amineptine (Survector): The Smart Tricyclic - Short overview, describing this drug as a mild stimulant and a fast-acting mood-brightener.
Meta Description: [ Amineptine ( Survector ) is a mild but pleasant stimulant and a fast-acting mood-brightener ]
Erowid Amineptine (Survector) Vault - Information about this drug, including pharmacology, abuse potential, side effects and withdrawal systems, and reasons it was removed from the market in many countries.
Meta Description: [ Information about Amineptine (Survector) ]
